Clinical Trial: The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD.

U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289750) titled 'The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD.' on Dec. 04.

Brief Summary: To compare the efficacy and safety of the combination of alogliptin and actoplus met with that of actoplus met alone in improving the glucose and lipid metabolism and pancreatic function in T2DM patients complicated with MAFLD.

Study Start Date: Feb. 01, 2026

Study Type: INTERVENTIONAL

Condition: T2DM MAFLD

Intervention: DRUG: combination treatment

combination of alogliptin and actoplus met

DRUG: alone treatment

actoplus met

Recruitment Status:...